A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
Clinical trial NCT02491684 · COMPLETED
Trial details
- NCT number
- NCT02491684
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-21
- Primary completion
- 2016-11-24
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.